Epigenetic Study Identifies Potential Drug Targets for a Rare Type of Bone Marrow Cancer
…with the overexpression of important leukemogenic driver genes. In particular, they saw a reduction in repressive histone methylation and a rise in permissive histone methylation and acetylation in promoter regions….